Literature DB >> 17621523

Acute ophthalmoparesis associated with anti-GM1, anti-GD1a, and anti-GD1b antibodies after enterovirus infection in a 6-year-old girl.

Carlo Fusco1, Gianna Bertani, Angela Scarano, Elvio Della Giustina.   

Abstract

This article presents a 6-year-old girl who developed acute unilateral third cranial nerve palsy in the absence of any other sign of central nervous system involvement. Raised titers of immunoglobulin M antibodies against GM1, GD1a, and GD1b ganglioside components were demonstrated. Ten days earlier, the girl had experienced acute gastroenteritis with positive specific immunoglobulin M antibodies against enterovirus. The results of all other laboratory tests usually performed for infectious diseases were negative, and neuroradiologic findings were also normal. Oral prednisone was administered for a few days, and the ophthalmoparesis fully resolved within 1 month. Two months later, a second episode of isolated ophthalmoparesis occurred, again associated with a positive immunoglobulin M reaction against GM1, GD1a, and GD1b antigens. This report discusses the relationship between acute isolated ophthalmoparesis and antiganglioside antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621523     DOI: 10.1177/0883073807301921

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  Weakness in both lower limbs for 1 week and blepharoptosis for 3 days in a boy aged 1 year and 7 months.

Authors:  Chang-Hui Lang; Mao-Qiang Tian; Xiao-Mei Shu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

2.  Bickerstaff's brainstem encephalitis associated with anti-GM1 and anti-GD1a antibodies.

Authors:  Jonathan Cleaver; Richard James; Gurjit Chohan; Paul Lyons
Journal:  BMJ Case Rep       Date:  2020-09-18

3.  Guillain-Barré and Miller Fisher Overlap Syndrome Mimicking Alimentary Botulism.

Authors:  Gabriela Moreno Legast; Agustina M Lascano; Markus Gschwind; Armin Schnider; Nicolas Nicastro
Journal:  J Clin Neurol       Date:  2017-10       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.